Sex moderates the impact of diagnosis and amyloid PET positivity on hippocampal subfield volume

Manuscript Number: 

18-0028R2

Author(s): 
Sarah J. Banks, Jody-Lynn Berg, Jessica Z.K. Caldwell, Jeffrey Cummings, Guogen Shan

Disclosures

Sarah J. Banks

  • Nothing to Disclose

Jody-Lynn Berg

  • Nothing to Disclose

Jessica Z.K. Caldwell

  • Nothing to Disclose

Jeffrey Cummings

  • Consulting Fees:
    Dr. Cummings has provided consultation to Acadia, Accera, Actinogen, ADAMAS, Alkahest, Allergan, Alzheon, Avanir, Axovant, Axsome, BiOasis Technologies, Biogen, Bracket, Eisai, Genentech, Grifols, Kyowa, Lilly, Lundbeck, Medavante, Merck, Neurocog, Nutricia, Otsuka, QR Pharma, Resverlogix, Roche, Samus, Servier, Suven, Takeda, Toyoma, and United Neuroscience companies.
    Equity:
    Dr. Cummings owns stock in ADAMAS, Alzheon, BioAsis, EIP Pharma, Prana, Sonexa, MedAvante, Neurotrax, and QR Pharma.
    Patents/Royalties
    Dr. Cummings owns the copyright of the Neuropsychiatric Inventory (NPI).
    Grants
    • Agency: 
      Teva Pharmaceuticals
      Dates: 
      02/15/2014 - 02/15/2018
    • Agency: 
      Avid Radiopharmaceuticals
      Dates: 
      02/15/2014 - 02/15/2018

Guogen Shan

  • Nothing to Disclose